摘要
目的:探讨骨髓增生异常综合征RA型(MDS-RA)的血液、骨髓涂片、骨髓病理组织学等的改变,为其疑难病例提供诊断价值。方法:将近几年的MDS资料中筛选MDS-RA被诊断时的资料,进行相关指标统计分析。结果:外周血:以二系或三系减少者为多见;49%的患者可见幼红细胞,44%的患者可见白细胞异常改变;骨髓涂片:以增生活跃和增生低下多见,病态造血者占83%(66/79)例,骨髓病理:以增生活跃为多见;粒系前体细胞增多者32例(41%),可见或偶见"幼稚前体细胞异常定位"(ALIP)者56例(71%);幼红细胞发育滞停,可见原红细胞岛、同一发育阶段的幼红细胞岛占58(73%)例,有异型巨核细胞者56(71%)例,纤维组织增多占72(91%)。结论:骨髓活组织检查对MDS-RA必不可少的联合诊断方法。
Objective:To study the changes of clinical features, bone marrow smears and bone marrow biopsy of Myelodysplastic Syndrome RA(MDS-RA) in order to provide value for the diagnosis of questionable cases. Method:The MDS-RA data were selected from the mylodysplastic syndrome data in the last few years and statistical analysed. Result:In clinical features, we found that there were more patients with two or three lineage cytopenia; 49% of patients had normoblast and 44% of patients had leucocyte abnormal changes. In bone marrow smears, we found that there were more patients with active hyperplasia and hypoplasia, and dyshaematopoiesis accounted for 83 % (66/79). In bone marrow biopsy, we found that there were more patients with active hyperplasia; there were 32 patients(41%) with increased granulocyte precursor cells, 56 patients(71%) with abnormal location of immature precursor (ALIP); and development of normoblasts was stopped, so there were 58 patients (73 %) with proerythroblast and normoblast island, 56 patients(71%) with abnormal megakaryocytes, and 72 patients(91%) with increased fibrous tissues. Conclusion: Bono marrow biopsy is an essential method for the diagnosis of MDS-RA.
出处
《临床血液学杂志(输血与检验)》
CAS
2008年第5期532-534,共3页
Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)